Article

Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype

2020-06-02

Abstract excerpt

Understanding the drivers of recurrence in aggressive prostate cancers requires detailed molecu-lar and genomic understanding in order to aid therapeutic interventions. Here we present a case study of a 70 year old male with high-grade clinically-localised acinar adenocarcinoma treated with definitive hormone therapy and radiotherapy. The patient progressed rapidly with rising PSA and succumbed without metastasis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36c3fc07-9fee-554f-bc7e-0c1fc3ddac78
DOI: 10.1101/2020.06.01.20115345

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotypeDOI 10.1101/2020.06.01.20115345Read

Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report.Semantic proximity Read

Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical OutcomesSemantic proximity Read

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate CancerSemantic proximity Read

Molecular model for neuroendocrine prostate cancer progressionSemantic proximity Read

Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive diseaseSemantic proximity Read

Determinant of aggressive phenotype in metastatic hormone sensitive prostate cancer depends on an intrinsic, highly aggressive cell cluster: Integrated single- cell and whole transcriptomic analysesSemantic proximity Read

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerSemantic proximity Read

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccineSemantic proximity Read

De Novo Metastatic Prostate Cancer: Are We Moving towards a Personalized Treatment?Semantic proximity Read

Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate CancerSemantic proximity Read

Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancerSemantic proximity Read

Treatment-related Neuroendocrine Prostate Carcinoma—Diagnostic and Molecular CorrelatesSemantic proximity Read